Editorial: Polycystic ovary syndrome (PCOS): Mechanism and management

Yishu Wang; Peter Leung; Rong Li; Yanting Wu; Hefeng Huang

doi:10.3389/fendo.2022.1030353

Editorial: Polycystic ovary syndrome (PCOS): Mechanism and management

Front Endocrinol (Lausanne). 2022 Oct 7:13:1030353. doi: 10.3389/fendo.2022.1030353. eCollection 2022.

Authors

Yishu Wang^{1

2

3}, Peter Leung⁴, Rong Li^{5

6}, Yanting Wu^{2

3

7}, Hefeng Huang^{2

3

7}

Affiliations

¹ International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
² Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, China.
³ Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, China.
⁴ Department of Obstetrics and Gynaecology, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.
⁵ Centre for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
⁶ National Clinical Research Centre for Obstetrics and Gynecology, Beijing, China.
⁷ Research Units of Embryo Original Diseases, Chinese Academy of Medical Sciences, Shanghai, China.

No abstract available

Keywords: Polycystic Ovary Syndrome (PCOS); clinical management, microbiome; obstetrical complications; offspring health; pathophysiology, diagnosis; prevention.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Female
Humans
Polycystic Ovary Syndrome* / therapy
Risk Factors